This is a Advanced Science news story, published by Phys Org, that relates primarily to DOPE-Cx news.
For more Advanced Science news, you can click here:
more Advanced Science newsFor more drug discoveries news, you can click here:
more drug discoveries newsFor more news from Phys Org, you can click here:
more news from Phys OrgOtherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best health news, business news, entertainment news, and much more. If you like drug discoveries news, you might also like this article about
zwitterionic phospholipids. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest conventional phospholipids news, new phospholipid news, drug discoveries news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!
lipid nanoparticlesPhys Org
•Health
Health
91% Informative
A new phospholipid, DOPE-Cx , can form a special structure called a "cubic phase," which helps overcome a major challenge in mRNA delivery by LNPs: endosomal escape.
Phospholipids are key components of cell membranes, and are used in the creation of lipid nanoparticles for targeted drug delivery.
The study was published in Advanced Science .
VR Score
93
Informative language
95
Neutral language
45
Article tone
formal
Language
English
Language complexity
87
Offensive language
not offensive
Hate speech
not hateful
Attention-grabbing headline
not detected
Known propaganda techniques
not detected
Time-value
long-living
External references
6
Source diversity
5
Affiliate links
no affiliate links
Small business owner?
